ID19152A - Senyawa-senyawa tersubstitusi sulfonilamida, proses untuk pembuatannya, penggunaannya sebagai obat-obatan atau diagnosa dan sediaan-sediaan farmasi - Google Patents

Senyawa-senyawa tersubstitusi sulfonilamida, proses untuk pembuatannya, penggunaannya sebagai obat-obatan atau diagnosa dan sediaan-sediaan farmasi

Info

Publication number
ID19152A
ID19152A IDP973864A ID973864A ID19152A ID 19152 A ID19152 A ID 19152A ID P973864 A IDP973864 A ID P973864A ID 973864 A ID973864 A ID 973864A ID 19152 A ID19152 A ID 19152A
Authority
ID
Indonesia
Prior art keywords
nme2
ome
nhso2me
so2me
so2nh2
Prior art date
Application number
IDP973864A
Other languages
English (en)
Inventor
Joachim Brendel
Hans Jochen Lang
Uwe Gerlach
Klaus Weidmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996152213 external-priority patent/DE19652213A1/de
Priority claimed from DE1997130326 external-priority patent/DE19730326A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID19152A publication Critical patent/ID19152A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/16—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
IDP973864A 1996-12-16 1997-12-11 Senyawa-senyawa tersubstitusi sulfonilamida, proses untuk pembuatannya, penggunaannya sebagai obat-obatan atau diagnosa dan sediaan-sediaan farmasi ID19152A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996152213 DE19652213A1 (de) 1996-12-16 1996-12-16 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1997130326 DE19730326A1 (de) 1997-07-15 1997-07-15 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ID19152A true ID19152A (id) 1998-06-18

Family

ID=26032247

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973864A ID19152A (id) 1996-12-16 1997-12-11 Senyawa-senyawa tersubstitusi sulfonilamida, proses untuk pembuatannya, penggunaannya sebagai obat-obatan atau diagnosa dan sediaan-sediaan farmasi

Country Status (24)

Country Link
US (1) US5856338A (id)
EP (1) EP0847996B1 (id)
JP (1) JP4317601B2 (id)
KR (1) KR19980064151A (id)
CN (1) CN1185435A (id)
AT (1) ATE234821T1 (id)
AU (1) AU725699B2 (id)
BR (1) BR9706142A (id)
CA (1) CA2224885A1 (id)
CZ (1) CZ403997A3 (id)
DE (1) DE59709560D1 (id)
DK (1) DK0847996T3 (id)
ES (1) ES2195071T3 (id)
HR (1) HRP970684A2 (id)
HU (1) HUP9702475A3 (id)
ID (1) ID19152A (id)
IL (1) IL122576A0 (id)
NO (1) NO975887L (id)
NZ (1) NZ329200A (id)
PL (1) PL323809A1 (id)
PT (1) PT847996E (id)
SI (1) SI0847996T1 (id)
SK (1) SK171797A3 (id)
TR (1) TR199701605A2 (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
AU5542101A (en) 2000-04-14 2001-10-30 Univ Vanderbilt Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
TWI357901B (en) * 2004-03-12 2012-02-11 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivati
CN113402476B (zh) * 2021-06-21 2022-04-19 广东湛江海洋医药研究院 一种亚胺噁嗪衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
ES2145129T3 (es) * 1992-08-17 2000-07-01 Chugai Pharmaceutical Co Ltd Derivados de benzopirano y benzoxazina.
PT807629E (pt) * 1996-05-15 2004-07-30 Aventis Pharma Gmbh Cromanos substituidos por sulfonamidas processo para a sua preparacao a sua utilizacao como medicamentos ou agentes de diagnostico bem como medicamentos que os contem

Also Published As

Publication number Publication date
MX9710126A (es) 1998-07-31
HRP970684A2 (en) 1998-10-31
AU725699B2 (en) 2000-10-19
SI0847996T1 (en) 2003-08-31
CA2224885A1 (en) 1998-06-16
SK171797A3 (en) 1998-07-08
DK0847996T3 (da) 2003-06-30
HUP9702475A2 (hu) 1999-06-28
HUP9702475A3 (en) 2000-01-28
EP0847996B1 (de) 2003-03-19
NO975887D0 (no) 1997-12-15
IL122576A0 (en) 1998-06-15
ES2195071T3 (es) 2003-12-01
TR199701605A2 (xx) 1998-07-21
ATE234821T1 (de) 2003-04-15
BR9706142A (pt) 1999-05-18
PT847996E (pt) 2003-07-31
DE59709560D1 (de) 2003-04-24
PL323809A1 (en) 1998-06-22
US5856338A (en) 1999-01-05
CN1185435A (zh) 1998-06-24
CZ403997A3 (cs) 1998-07-15
JPH10182610A (ja) 1998-07-07
NZ329200A (en) 1999-05-28
AU4837397A (en) 1998-06-18
JP4317601B2 (ja) 2009-08-19
NO975887L (no) 1998-06-17
EP0847996A1 (de) 1998-06-17
HU9702475D0 (en) 1998-03-02
KR19980064151A (ko) 1998-10-07

Similar Documents

Publication Publication Date Title
ATE239680T1 (de) Sulfonamid derivate und deren verwendung
HUP0300922A2 (hu) Új vegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2192394T3 (es) Profarmacos de inhibidores de la bomba de protones.
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DE69901006D1 (de) Benzothiophen-, Benzofuran- und Indolderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2021266B3 (es) Nuevos derivados de quinazolina, procedimiento para su produccion y composiciones farmaceuticas que los contienen.
ATE21894T1 (de) Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln.
DE69331122D1 (de) 4-Aminochinazolin-Derivate, deren Verwendung als Heilmittel
ATE128623T1 (de) Mittel zur verbesserung von arzneimitteleffekten für antitumormittel.
FI831604A0 (fi) Pyridinderivat, deras framstaellning och anvaendning
SE7908995L (sv) Heterocykliska foreningar
AR034423A1 (es) Imidazotriazinonas sustituidas, un procedimiento para su preparacion, medicamentos y el uso de dichas imidazotriazinonas para la preparacion de medicamentos
DK0629211T3 (da) 4-Oxo-2-thioxoimidazolidin-derivater som inhibitorer af blodpladeaggragation
DK1732929T3 (da) Tricyklisk benzopyranforbindelse som anti-arytmika
ATE120191T1 (de) Makrocyclische chelatisierungsmittel und daraus hergestellte chelate.
ID19152A (id) Senyawa-senyawa tersubstitusi sulfonilamida, proses untuk pembuatannya, penggunaannya sebagai obat-obatan atau diagnosa dan sediaan-sediaan farmasi
SE7606440L (sv) Nya n-substituerade bensensulfonamider och sett att framstella desamma
DE3586123D1 (de) Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3876402D1 (de) N-(2-alkyl-3-mercapto-1,5-dioxoalkyl)glycinamid-derivate und deren verwendung als kollagenase-inhibitoren.
ATE24321T1 (de) Heterozyklische verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE3687675D1 (de) Substituierte toluidine, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.
ATE9996T1 (de) N-substituierte 2,4-dialkoxybenzensulfonamide.
NZ335055A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents and process for its production
EA200400666A2 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
CA2381513A1 (en) Bicyclic-substituted 4-amino-pyridopyrimidine derivatives